Author

Yukihito Kajita

Observed names: Y. Kajita, YUKIHITO KAJITA

Institution: Yokohama City University

Observed institutions: Yokohama City University Medical Center, Yokohama City University Hospital, Yokohama City University

OpenAlex ID: A5014634511

Retrospective analysis of independent predictors of progression‐free survival in patients with EGFR mutation‐positive advanced non‐small cell lung cancer receiving first‐line osimertinib

2022 · Shuhei Teranishi, Chihiro Sugimoto, et al. · Thoracic Cancer · 20

Real‐world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non‐small cell lung cancer

2024 · Ayami Kaneko, Nobuaki Kobayashi, et al. · Thoracic Cancer · 11

Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes

2023 · Nobuaki Kobayashi, Kenji Miura, et al. · Cancers · 11

The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications

2025 · Nobuaki Kobayashi, Yukihito Kajita, et al. · Genes · 9

Comparison of the slow‐pull and aspiration methods of endobronchial ultrasound‐guided transbronchial needle aspiration for next‐generation sequencing‐compatible tissue collection in non‐small cell lung cancer

2023 · Yukihito Kajita, Shuhei Teranishi, et al. · Cancer Medicine · 5

Valid surrogate end-points in nonsmall cell lung cancer peri-operative systemic therapy trials: a systematic review

2025 · Kohei Somekawa, Nobuyuki Horita, et al. · European Respiratory Review · 3

Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non‐small cell lung carcinoma

2023 · Nobuyuki Hirama, Masaki Yamamoto, et al. · Thoracic Cancer · 2

Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report

2023 · Shuntaro Hiro, Shuhei Teranishi, et al. · Thoracic Cancer · 2

Real-world efficacy of immune checkpoint inhibitors in PD-L1 negative non-small cell lung cancer: a multicenter retrospective study

2025 · Suguru Muraoka, Nobuaki Kobayashi, et al. · Translational Lung Cancer Research · 1

Rapid detection of non-small cell lung cancer driver mutations using droplet digital polymerase chain reaction analysis of bronchial washings: a prospective multicenter study

2025 · Kohei Somekawa, Nobuaki Kobayashi, et al. · Translational Lung Cancer Research · 1

Total baseline tumor size predicts survival among patients with advanced small-cell lung cancer receiving chemotherapy plus programmed death-ligand 1 inhibitor as first-line therapy: a multicenter retrospective observational study

2024 · Anna Tanaka, Shuhei Teranishi, et al. · Frontiers in Oncology · 1

Primary tracheal small‐cell carcinoma detected 11 months after surgery for pulmonary large‐cell neuroendocrine carcinoma: A case report

2023 · Chihiro Sugimoto, Shuhei Teranishi, et al. · Thoracic Cancer · 1

Lactate dehydrogenase-to-lymphocyte ratio predicts overall and progression-free survival among patients with advanced small-cell lung cancer receiving first-line chemoimmunotherapy: A two-center retrospective observational study

2026 · Tomofumi Hirose, Shuhei Teranishi, et al. · Medicine

Nab-paclitaxel or Paclitaxel Treatment for Relapsed Small Cell Lung Cancer: A Single-arm Meta-analysis

2026 · SOUSUKE KUBO, KOHEI SOMEKAWA, et al. · Anticancer Research

1019P High-sensitivity and rapid detection of driver mutations in non-small cell lung cancer using droplet digital PCR analysis of bronchial wash fluid

2025 · K. Somekawa, N. Kobayashi, et al. · Annals of Oncology

The predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unrescectable locally advanced non-small cell lung carcinoma

2023 · Nobuyuki Hirama, Masaki Yamamoto, et al. · European Respiratory Journal

Works count: 16

Citation count: 67

H-index: 5

I10-index: 3